Correlation Between DiaMedica Therapeutics and Neximmune
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Neximmune, you can compare the effects of market volatilities on DiaMedica Therapeutics and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Neximmune.
Diversification Opportunities for DiaMedica Therapeutics and Neximmune
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between DiaMedica and Neximmune is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Neximmune go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Neximmune
If you would invest 543.00 in DiaMedica Therapeutics on November 5, 2024 and sell it today you would earn a total of 33.00 from holding DiaMedica Therapeutics or generate 6.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 5.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Neximmune
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
DiaMedica Therapeutics and Neximmune Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Neximmune
The main advantage of trading using opposite DiaMedica Therapeutics and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |